Moderna and Merck mRNA Melanoma Vaccine Clears Phase 3, Setting Stage for First Personalized Cancer Shot
Moderna and Merck & Co. announced Wednesday August 19 positive Phase 3 results for mRNA-4157-V1, an individualized mRNA cancer vaccine against…
26 days ago